TRAF7 also serves as a biomarker for adenomatoid tumors of the genital tract, which are benign serosal mesothelial tumors with a favorable prognosis, distinguishing them from malignant mesothelial tumors that have a much poorer prognosis (Goode et al. 2018; Itami et al. 2021). The gene discussed is TRAF7; the disease is malignant mesothelioma.